<DOC>
	<DOCNO>NCT00538109</DOCNO>
	<brief_summary>An Open-Label , Multicenter , Expanded Access Study Oral AMN 107 Adult Patients Imatinib ( Glivec速/Gleevec速_ - Resistant Intolerant Chronic Myeloid Leukemia Blast Crisis , Accelerated Phase Chronic Phase</brief_summary>
	<brief_title>An Open-Label , Multicenter , Expanded Access Study Oral AMN 107 Adult Patients With Imatinib ( Glivec速/Gleevec速_ - Resistant Intolerant Chronic Myeloid Leukemia Blast Crisis , Accelerated Phase Chronic Phase</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Blast Crisis</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Patients Imatinib ( Glivec/Gleevec ) Resistant Intolerant CML Blast Crisis , Accelerated Phase Chronic Phase</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>CML Blast Crisis</keyword>
	<keyword>Accelerated Phase oe Chronic Phase</keyword>
</DOC>